Tumor Session


Back to Package

image

Designed specifically for the tumor subspecialty, hear the latest research with key takeaways that help practices update and improve approaches to patient care. The session provides 3.25 CME.

Pricing

AANS Member$49
Non-member$79

Faculty

Faculty

  • Zsolt Zador, MD, PhD - Awarded The American Brain Tumor Association Young Investigator Award
  • Addison Barnett, MS - Awarded The Journal of Neuro-Oncology Award
  • Sebastian Ille, MD - Awarded The Brainlab Neurosurgery Award
  • Akiyoshi Ogino, M.D., PhD - Awarded The Leksell Radiosurgery Award
  • David S. Baskin, MD, FAANS, FACS - Awarded The Integra Foundation Award
  • Sakibul Huq - Awarded The Brian D. Silber Award
  • Pablo Valdes Quevedo, MD - Awarded The Ronald L. Bittner Award on Brain Tumor Research
  • Sricharan Gopakumar - Awarded The AANS/CNS Section on Tumors Neuro-Oncology Trainee Award 
  • Siri Sahib Singh Khalsa, MD - Awarded The Louise Eisenhardt Travel Scholorship
  • Nikita Lakomkin
  • Reinier Alvarez
  • Rushikesh Sanjeev Joshi
  • Koray Ozduman, MD, IFAANS
  • Riccardo Serra
  • Veit Stoecklein
  • Daniel Zhang
  • Christopher S. Hong, MD
  • Anudeep Yekula, MD
  • Leo Kim
  • Frank Joseph Attenello III, MD
  • Ashish Shah, MD
  • Florian Scheichel

Learning Objectives

After completing this educational activity, participants should be able to:

  • Discuss research updates in tumor neurosurgery
  • Apply updates in tumor neurosurgery to practice

CME Accreditation

The AANS designates this internet enduring material activity for a maximum of 3.25 AMA PRA Category 1 Credits™.

Disclosure Information

As a provider accredited by the Accreditation Council for Continuing Medical Education (ACCME), the AANS must ensure balance, independence, objectivity, and scientific rigor in all of its sponsored educational activities. In accordance with the ACCME’s Standards for Commercial Support, the AANS is required to disclose to the activity audience the relevant financial relationships of the planners, faculty and any other individual in a position to control content of this activity.

Please find the relevant financial relationships disclosed below for all individuals in control of content. All conflicts of interest have been resolved in accordance with ACCME Standards for Commercial Support.

Name

Relationship/Company

Akiyoshi Ogino, M.D., Ph.D.

Stock Shareholder (purchased direct, i.e. not through Mutual Fund, retirement package, etc.) – Elekta ab

Board, Trustee, Officer, Leadership position specifically with a neurosurgical or medical-related associated, non-profit or similar entity – Insightec

Grants/Research Support - Japan society for the promotion of science

Riccardo Serra

Consultant Fees - AsclepiX Therapeutics, StemGen, InSightec, Accelerating Combination Therapies, Camden Partners,  LikeMinds, Inc, Galen Robotics, Inc., Nurami Medical

Planners, faculty and any other individuals in control of content not listed have indicated that they have no relevant financial relationships to disclose for this activity.

Disclaimer

The opinions expressed in this educational activity are those of the author and do not necessarily represent the views of the grant provider or the AANS. This educational activity does not endorse one particular type of instrumentation, nor is it intended to dictate an exclusive course of management. It presents one of numerous recognized methods of clinical practice for consideration by physicians for incorporation into their practices. Variations of practice taking into account the needs of the individual patient, resources and limitations unique to the institution or type of practice may be appropriate. Disclosure about patient confidentiality, standards of care or course of management does not imply endorsement or disapproval of products.

Please Note: It is recognized that the use of non-FDA approved devices is described in some of the published material, but these techniques are often the standard of care and may be of value to the patients served.

Accreditation Designation

The AANS is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The AANS designates this internet enduring material activity for a maximum of 3.25 AMA PRA Category 1 Credits.

Physicians should claim only credit commensurate with the extent of their participation in the activity.

Term of approval is for three years, beginning from 05/27/2020 until 05/27/2023.

© 2020 American Association of Neurological Surgeons

Key:

Complete
Failed
Available
Locked
Distinct Regional Activity And Ontogeny Of Tumor Associated Macrophages In Human Glioblastoma Suggests Parallel Recruitment Processes.
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Zsolt Zador, MD, PhD
Sex-Associated Analysis of MGMT Promoter Site Methylation
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Addison Barnett, MS, NMBR PHD
Navigated Repetitive Transcranial Magnetic Stimulation Improves the Outcome of Postsurgical Ischemia-related Paresis in Glioma Patients – A Randomized, Sham-controlled Double-blinded Trial
Open to view video.
Open to view video. Sebastian Ille, MD
Useful Hearing Preservation Is Improved in Vestibular Schwannoma Patients Who Undergo Stereotactic Radiosurgery Before Further Hearing Deterioration Ensues
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Akiyoshi Ogino, M.D., Ph.D.
Characterization of Rathke’s Cleft Cyst (RCCs) by 1H-MRS: Differential Diagnosis of Pituitary Adenomas and RCCs
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. David S. Baskin, MD, FAANS, FACS
Epigenetic Modulation As A Novel Treatment Strategy for Chordoma
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Sakibul Huq
Protein Decrowding ExM For Discovery Of Previously Unidentified Structures And Cell Populations In Gliomas
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Pablo Valdes Quevedo, MD
Oncolytic Viral Delivery Into The Surgical Resection Cavity For The Treatment Of Glioblastoma In A Murine Model
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Sricharan Gopakumar
Automated Intraoperative Frozen Diagnosis of Brain Tumors Using Machine Learning
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Siri Sahib Singh Khalsa, MD
The Safety and Feasibility of Brain Tumor Resection in the Outpatient Setting – A Pilot Study
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Nikita Lakomkin
Evading Death: NOXA In Cushing’s Disease Pituitary Adenomas
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Reinier Alvarez
Predictors of Postoperative Diabetes Insipidus (DI) in Over 1000 Patients Undergoing Transsphenoidal Surgery: A Single Institution Experience
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Rushikesh Sanjeev Joshi
IDH-Mutant Gliomas Differ in Distribution of Mitochondrial Genomic Alterations
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Koray Ozduman, MD, IFAANS
Local Combination Therapy of Poly-ADP-Ribose-Polymerase-Inhibitor Olaparib and Temozolomide-Etoposide From a Biodegradable Paste Potentiates Radiotherapy and Prolongs Survival
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Riccardo Serra
Resting-state fMRI Detects Alterations in Whole Brain Connectivity Related to Tumor Biology in Glioma Patients
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Veit Stoecklein
Modeling the Genetic, Transcriptomic, and Cell Surface Antigen Heterogeneity of Glioblastoma Using Patient Derived Tumor Organoids
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Daniel Zhang
Exploiting Inherent DNA Damage Repair Defects in IDH1/2 Mutated Gliomas With the CNS-Penetrant PARP Inhibitor BGB290
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Christopher S. Hong, MD
Longitudinal Analysis of Serum-derived Extracellular RNA for Monitoring of Treatment Response to Dacomitinib in Adult Patients with EGFR Amplified Recurrent Glioblastoma
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Anudeep Yekula, MD
Reprogrammed TCA Cycle Maintains a Stem-Like Epitranscriptome and Therapeutic Persistence in Glioblastoma Stem Cells
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Leo Kim
Identification of 48 Novel Long Noncoding RNAs (lncRNAs) Modulating Glioblastoma Invasion via CRISPR-Interference Functional Screen
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Frank Joseph Attenello III, MD
Survival benefit of lobectomy for glioblastoma: moving towards radical supramaximal resection.
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Ashish Shah, MD
Diagnostic Yield of Biopsy in Corticosteroid Pre-Treated Patients with Primary Central Nervous System Lymphoma
Select the "View On-Demand Recording" button to begin.
Select the "View On-Demand Recording" button to begin. Florian Scheichel
CME Accreditation
CME Posttest
10 Questions  |  2 attempts  |  7/10 points to pass
10 Questions  |  2 attempts  |  7/10 points to pass
Evaluation
8 Questions
Certificate
3.25 AMA PRA Category 1 CreditsTM credits  |  Certificate available
3.25 AMA PRA Category 1 CreditsTM credits  |  Certificate available